You may have heard of Ozempic, and other GLP-1 drugs. They’re everywhere. And they typically involve weekly injections — which can have a sticker price of over a thousand dollars a month. And insurance coverage has been tricky to navigate for a lot of people. That’s why there’s a lot of excitement around a new pill form of the drug. NPR Pharmaceuticals Correspondent <a href="https://www.npr.org/people/825275572/sydney-lupkin"target="_blank" >Sydney Lupkin </a>chats about these experimental pills with host <a href="https://www.npr.org/people/767284140/emily-kwong"target="_blank" >Emily Kwong</a>.  Check out more of NPR’s <a href="https://www.npr.org/2025/11/25/nx-s1-5619816/obesity-pills-wegovy-semaglutide-orforglipron"target="_blank" >coverage </a>about GLP-1s. Interested in more health stories? Email us your question at <a href="mailto:shortwave@npr.org"target="_blank" >shortwave@npr.org</a>. Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at <a href="http://plus.npr.org/shortwave"target="_blank" >plus.npr.org/shortwave</a>. Learn more about sponsor message choices: <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a> <a href="https://www.npr.org/about-npr/179878450/privacy-policy">NPR Privacy Policy</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

GLP-1 Pills Are On The Way. Here's What To Know

Short Wave

AI Chapters

AI Insights

Reviews